David Ribeiro
COO ARC Regulatory
Seminars
Wednesday 20th May 2026
Designing Early-Phase Translational Medicine Studies for Success: Approaches to Accelerate Patient Enrolment
9:00 am
- This session will explore practical approaches to designing early-phase translational medicine studies that are both scientifically robust and operationally feasible
- Drawing on ARC Regulatory’s integrated capabilities across Dx CRO, Lab Services, and Pharma Tech, the discussion will highlight how combining regulatory strategy, clinical operations, and innovative technologies can streamline study design and execution.
